Maculopathy and Spinocerebellar Ataxia Type 1: A New Association?

被引:9
|
作者
Lebranchu, Pierre [1 ]
Le Meur, Guylene [1 ]
Magot, Armelle [2 ]
David, Albert [3 ]
Verny, Christophe [4 ]
Weber, Michel [1 ]
Milea, Dan [5 ,6 ,7 ,8 ]
机构
[1] Nantes Univ Hosp, Dept Ophthalmol, Nantes, France
[2] Nantes Univ Hosp, Lab Explorat Fonct, Nantes, France
[3] Nantes Univ Hosp, Dept Genet, Nantes, France
[4] Angers Univ Hosp, Dept Neurol, Angers, France
[5] Angers Univ Hosp, Dept Ophthalmol, Angers, France
[6] Copenhagen Univ Hosp, Dept Ophthalmol, Copenhagen, Denmark
[7] Singapore Natl Eye Ctr, Singapore, Singapore
[8] Singapore Eye Res Inst, Singapore, Singapore
关键词
DOMINANT CEREBELLAR-ATAXIA; CONE-ROD DYSTROPHY; CYCLASE-ACTIVATING PROTEIN-1; MACULAR DYSTROPHY; GENE; DEGENERATION; SCA1; MUTATIONS; PHENOTYPE; EXPANSION;
D O I
10.1097/WNO.0b013e31828d4add
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background:Autosomal dominant cerebellar ataxia is a rare heterogeneous group of diseases characterized by cerebellar symptoms, often associated with other multisystemic signs. Mild optic neuropathy has been associated with spinocerebellar ataxia type 1 (SCA1), but macular dysfunction has been reported in only 2 cases. We report the first family with SCA1 with several members affected by visual loss related to maculopathy.Methods:Cross-sectional clinical and electrophysiological study of a family with genetically confirmed SCA1. Patients with unexplained visual loss were included.Results:Four patients from the same family, carrying the same genetic mutation, were examined. Testing revealed an increased CAG trinucleotide repeat number within the SCA1 gene. Genetic testing results for SCA7 were negative. Visual acuities ranged between 20/20 and 20/200. Visual fields revealed central scotomas in most of the eyes, and funduscopy was unremarkable in most patients. Central retinal thinning of the retina or disorganized photoreceptor layers were found with optical coherence tomography (OCT). In one patient, multifocal electroretinography (mfERG) revealed central retinal dysfunction.Conclusions:A clinically subtle or even occult maculopathy can occur in association with SCA1. Macular OCT and mfERG can be abnormal even in asymptomatic patients. Unexplained visual loss in SCA1 patients should prompt evaluation of macular function, even if clinical signs of maculopathy are absent.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 50 条
  • [31] Spinocerebellar ataxia type 14 - Opening a new door in dominant ataxia research?
    Pandolfo, M
    van de Warrenburg, BPC
    NEUROLOGY, 2005, 64 (07) : 1113 - 1114
  • [32] Spinocerebellar Ataxia Type 2
    Scoles, Daniel R.
    Pulst, Stefan M.
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 175 - 195
  • [33] Spinocerebellar ataxia type 15
    Gardner, RJM
    Knight, MA
    Hara, K
    Tsuji, S
    Forrest, SM
    Storey, E
    CEREBELLUM, 2005, 4 (01): : 47 - 50
  • [34] Spinocerebellar ataxia type 15
    R. J. Mckinlay Gardner
    Melanie A. Knight
    Kenju Hara
    Shoji Tsuji
    Susan M. Forrest
    Elsdon Storey
    The Cerebellum, 2005, 4 : 47 - 50
  • [35] Spinocerebellar Ataxia Type 2
    Pulst, Stefan M.
    NEUROLOGY-GENETICS, 2025, 11 (01)
  • [36] Spinocerebellar ataxia type 20
    Storey, E
    Knight, MA
    Forrest, SM
    Gardner, RJM
    CEREBELLUM, 2005, 4 (01): : 55 - 57
  • [37] Progress in pathogenesis studies of spinocerebellar ataxia type 1
    Cummings, CJ
    Orr, HT
    Zoghbi, HY
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 1079 - 1081
  • [38] Spinocerebellar ataxia type 1 and familial spontaneous pneumothorax
    Fukazawa, T
    Sasaki, H
    Kikuchi, S
    Hamada, K
    Hamada, T
    Tashiro, K
    NEUROLOGY, 1997, 49 (05) : 1460 - 1462
  • [39] Spinocerebellar ataxia type 20
    Elsdon Storey
    Melanie A. Knight
    Susan M. Forrest
    R. J. Mckinlay Gardner
    The Cerebellum, 2005, 4 : 55 - 57
  • [40] Combinatorial Gene Therapy for Spinocerebellar Ataxia Type 1
    Keiser, Megan S.
    Carrell, Ellie M.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2019, 27 (04) : 33 - 34